Shalini Sharp Buys Shares of ONC
Shalini Sharp acquired 18,980 shares of ONC, highlighting insider activity.
Key Points
- On June 11, 2026, Shalini Sharp acquired 18,980 shares of ONC, reflecting active insider trading.
- ONC shares traded at $264.48 with analysts maintaining positive outlooks and setting high price targets.
- Other insiders, including Xiaodong Wang and Henry Lee, also bought significant shares on the same day.
Shalini Sharp, an insider at ONC, purchased 18,980 shares of the company on June 11, 2026. The transaction was executed without a predetermined plan, reflecting a notable insider activity as ONC shares were priced at $264.48.
Insider Buying and Selling at BeOne Medicines AG
The insider buying spree at ONC was not limited to Shalini Sharp. Xiaodong Wang acquired 193,492 shares, and Henry Lee, the Senior Vice President and General Counsel, purchased 45,071 shares. Additionally, Xiaodong Wang made another buy of 99,892 shares, and Charles Lazelle Sawyers bought 18,980 shares on the same day. These transactions were all executed at no cost, suggesting a distribution of shares rather than a market purchase.
Other Institutional Activity in ONC
Institutional investors have also been active in ONC. Baker Bros. Advisors LP maintained its position with 8,799,053 shares valued at approximately $2.61 billion. Primecap Management Co/CA/ slightly reduced its holdings by 5,400 shares, ending with 4,975,181 shares worth about $1.48 billion. Capital International Investors significantly cut back, shedding 955,140 shares to hold 4,158,726 shares valued at $1.23 billion. FMR LLC also reduced its stake by 299,017 shares, bringing its total to 3,693,610 shares, valued at $1.10 billion. Meanwhile, Citadel Advisors LLC nearly doubled its position, adding 516,719 shares to reach a total of 1,050,236 shares, valued at approximately $306.6 million.
Analysts Set New Price Targets
Analysts have been active in updating their outlooks for ONC. On June 2, 2026, RBC Capital maintained its "buy" rating with a price target of $436. On May 15, 2026, Leerink Partners also kept a "buy" rating, setting a target of $367. Guggenheim and Barclays both maintained "buy" ratings on May 7, 2026, with targets of $420 and $409, respectively. Truist Securities reiterated a "buy" rating with a target of $413 on the same day. Wells Fargo initiated coverage with a "buy" rating and a $400 target on May 4, 2026.
Bottom Line
The insider purchases at ONC, led by Shalini Sharp and other executives, suggest confidence in the company's future. Investors often track insider transactions for potential insights into a company's prospects. While these trades provide valuable context, they are backward-looking and do not guarantee future performance. Analyst ratings and institutional activity further enrich the narrative around ONC, offering a comprehensive view of market sentiment.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.
